Literature DB >> 8971554

The role of growth hormone in the regulation of body composition in the adult.

D L Russell-Jones1, A J Weissberger.   

Abstract

Despite early evidence from studies performed soon after its discovery, the role of human growth hormone (GH) in metabolic processes during adulthood has, until recently, been largely ignored. The importance of GH in the regulation of body composition in the adult is clearly demonstrated by the abnormalities seen in "nature's experiments', i.e. acromegaly and GH deficiency. Body composition has been shown to change favourably following successful treatment of acromegaly. Formal replacement studies in adult GH-deficient patients, made possible by the recent advent of recombinant GH, have also shown dramatic changes in body composition, with increases in lean body mass and reductions in fat mass towards normality and associated improvements in physical performance. Thus, adult GH deficiency, like acromegaly, has become widely accepted as a distinct clinical entity warranting treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971554

Source DB:  PubMed          Journal:  Growth Regul        ISSN: 0956-523X


  6 in total

1.  Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).

Authors:  Charles W Denko; Charles J Malemud
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

2.  Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.

Authors:  Pamela U Freda; Wei Shen; Steven B Heymsfield; Carlos M Reyes-Vidal; Eliza B Geer; Jeffrey N Bruce; Dympna Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

3.  Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry.

Authors:  Pamela U Freda; Wei Shen; Carlos M Reyes-Vidal; Eliza B Geer; Fernando Arias-Mendoza; Dympna Gallagher; Steven B Heymsfield
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

4.  Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly.

Authors:  Adriana P Kuker; Wei Shen; Zhezhen Jin; Simran Singh; Jun Chen; Jeffrey N Bruce; Pamela U Freda
Journal:  J Endocr Soc       Date:  2021-02-01

5.  The acromegaly lipodystrophy.

Authors:  Pamela U Freda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

Review 6.  Growth hormone and aging.

Authors:  A Bartke
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.